Genmab A/S (GMAB)
34.15
+1.50
(+4.59%)
USD |
NASDAQ |
Sep 15, 16:00
34.15
0.00 (0.00%)
After-Hours: 20:00
Genmab Price to Book Value : 3.423 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 3.423 |
| September 14, 2026 | 3.272 |
| September 11, 2026 | 3.254 |
| September 10, 2026 | 3.230 |
| September 09, 2026 | 3.311 |
| September 08, 2026 | 3.360 |
| September 04, 2026 | 3.368 |
| September 03, 2026 | 3.449 |
| September 02, 2026 | 3.429 |
| September 01, 2026 | 3.336 |
| August 31, 2026 | 3.323 |
| August 28, 2026 | 3.330 |
| August 27, 2026 | 3.418 |
| August 26, 2026 | 3.382 |
| August 25, 2026 | 3.444 |
| August 24, 2026 | 3.309 |
| August 21, 2026 | 3.352 |
| August 20, 2026 | 3.348 |
| August 19, 2026 | 3.419 |
| August 18, 2026 | 3.303 |
| August 17, 2026 | 3.291 |
| August 14, 2026 | 3.201 |
| August 13, 2026 | 3.141 |
| August 12, 2026 | 3.149 |
| August 11, 2026 | 3.092 |
| Date | Value |
|---|---|
| August 10, 2026 | 3.094 |
| August 07, 2026 | 3.132 |
| August 06, 2026 | 2.990 |
| August 05, 2026 | 2.932 |
| August 04, 2026 | 2.908 |
| August 03, 2026 | 2.874 |
| July 31, 2026 | 2.893 |
| July 30, 2026 | 2.870 |
| July 29, 2026 | 2.858 |
| July 28, 2026 | 2.906 |
| July 27, 2026 | 2.886 |
| July 24, 2026 | 2.893 |
| July 23, 2026 | 2.924 |
| July 22, 2026 | 2.891 |
| July 21, 2026 | 2.843 |
| July 20, 2026 | 2.797 |
| July 17, 2026 | 2.878 |
| July 16, 2026 | 2.904 |
| July 15, 2026 | 2.914 |
| July 14, 2026 | 2.879 |
| July 13, 2026 | 2.886 |
| July 10, 2026 | 2.906 |
| July 09, 2026 | 2.985 |
| July 08, 2026 | 2.961 |
| July 07, 2026 | 2.924 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Ascendis Pharma A/S | 9.588 |
| Zealand Pharma A/S | 1.090 |
| Bavarian Nordic A/S | 1.177 |
| Evaxion AS | 2.660 |
Price to Book Value Related Metrics
| PE Ratio | 27.04 |
| PS Ratio | 5.273 |
| Price to Free Cash Flow | 25.04 |
| Price | 34.15 |
| Earnings Yield | 3.70% |
| Market Cap | 20.39B |
| Operating PE Ratio | 16.34 |
| Normalized PE Ratio | 22.16 |